Vivos Therapeutics VVOS
Last Price
52 Week Range
$1.93 - $7.95
Next Earnings Date
Mar 30 2026 (Estimate)
Next Earnings Date
Mar 30 2026 (Est.)
Last Price
VVOS Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Vivos Therapeutics, Inc. | 8-K | December 17, 2025 | |
Vivos Therapeutics, Inc. | 8-K | December 5, 2025 | |
Vivos Therapeutics, Inc. | 8-K | November 19, 2025 | |
Vivos Therapeutics, Inc. | 10-Q | November 19, 2025 | |
Vivos Therapeutics, Inc. | 8-K | November 4, 2025 | |
Vivos Therapeutics, Inc. | 8-K | October 24, 2025 | |
Vivos Therapeutics, Inc. | DEF 14A | September 29, 2025 | |
Vivos Therapeutics, Inc. | 8-K | September 18, 2025 | |
Vivos Therapeutics, Inc. | 8-K | September 12, 2025 | |
Vivos Therapeutics, Inc. | 8-K | August 20, 2025 | |
Vivos Therapeutics, Inc. | 10-Q | August 19, 2025 | |
Vivos Therapeutics, Inc. | 8-K | June 13, 2025 | |
Vivos Therapeutics, Inc. | 8-K | June 6, 2025 | |
Vivos Therapeutics, Inc. | 8-K | May 23, 2025 | |
Vivos Therapeutics, Inc. | 10-Q | May 15, 2025 | |
Vivos Therapeutics, Inc. | 8-K | May 15, 2025 | |
Vivos Therapeutics, Inc. | 8-K | April 17, 2025 | |
Vivos Therapeutics, Inc. | 10-K | March 31, 2025 | |
Vivos Therapeutics, Inc. | 8-K | March 31, 2025 | |
Vivos Therapeutics, Inc. | 8-K | February 14, 2025 | |
Vivos Therapeutics, Inc. | 8-K | December 23, 2024 | |
Vivos Therapeutics, Inc. | 8-K | November 27, 2024 | |
Vivos Therapeutics, Inc. | 10-Q | November 14, 2024 | |
Vivos Therapeutics, Inc. | 8-K | November 14, 2024 | |
Vivos Therapeutics, Inc. | DEFA14A | November 6, 2024 | |
Vivos Therapeutics, Inc. | DEF 14A | October 7, 2024 | |
Vivos Therapeutics, Inc. | 8-K | September 20, 2024 | |
Vivos Therapeutics, Inc. | 8-K | September 18, 2024 | |
Vivos Therapeutics, Inc. | 8-K | September 17, 2024 | |
Vivos Therapeutics, Inc. | 8-K | September 12, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.